LD-2 disclosure · 1st Quarter - Report
LYNDRA THERAPEUTICS
Income$60Kfee reported
Client
- Description
- Ultra-long acting therapeutic medicine
- Location
- Massachusetts · United States of America
Registrant
- Description
- Government Affairs Firm
- Location
- Washington, District of Columbia, United States of America
Lobbying activities
1 issueHealth Issues
Defense Appropriations Act for Fiscal Year 2021/22 - ultra-long medicine delivery platform National Defense Authorization Act for Fiscal Year 2021/22 - ultra-long medicine delivery platform Labor Health & Human Services and Education Fiscal Year 2021/22 Appropriations Bill - ultra-long medicine delivery platform
LobbyistsJAMES L ERVIN · COLBY MILLER · JOHN BLOUNT
TargetedSENATE · HOUSE OF REPRESENTATIVES · Defense, Dept of (DOD)